Partner and Member of Management Committee, Deepa has been ranked for the second consecutive year, while this recognition marks the fifth time for Partner and Practice Lead (Life Sciences, Chem-Pharma) Amrish.

The IAM guide listed Deepa for her expertise in biotechnology, chemicals, legal, medical devices and pharmaceuticals/life sciences. As an experienced IP practitioner and a devoted life sciences researcher, Deepa is considered a leading advisor to domestic and international players in the life sciences field.

Amrish has been ranked for his exceptional skills in biotechnology, chemicals, energy/fuel, legal, materials, medical devices and pharmaceuticals/life sciences. With his extensive experience as a patent professional, Amrish has adeptly managed complex IP cases for clients from various domains in the life sciences sector.

The IAM Strategy 300 is an annual research project that identifies practitioners who are taking IP portfolio management to the next level, offering top-tier services to organizations. Through extensive annual research, only the best and the brightest in the field are listed.

In addition to this ranking, both Deepa and Amrish were listed by IAM Patent 1000 in June as ‘Recommended Individual’ and ‘Highly Recommended Individual’ in Prosecution, respectively.

Congratulations to our colleagues on their well-deserved achievement!